Lepu Biopharma Co., Ltd. (HKG:2157)
Hong Kong · Delayed Price · Currency is HKD 5.30
+0.02 (0.38%)
Jan 21, 2026, 4:08 PM HKT
Lepu Biopharma Market Cap
Lepu Biopharma has a market cap or net worth of 9.53 billion as of January 21, 2026. Its market cap has increased by 111.77% in one year.
Market Cap
9.53B
Enterprise Value
9.91B
Revenue
767.54M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.30
Market Cap Chart
Since February 23, 2022, Lepu Biopharma's market cap has decreased from 11.84B to 9.53B, a decrease of -19.55%. That is a compound annual growth rate of -5.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 9.53B | 6.24% |
| Dec 31, 2025 | 8.97B | 100.10% |
| Dec 31, 2024 | 4.48B | -35.85% |
| Dec 29, 2023 | 6.99B | -42.72% |
| Dec 30, 2022 | 12.20B | 3.00% |
| Feb 23, 2022 | 11.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 291.88B |
| Hansoh Pharmaceutical Group Company | 260.32B |
| JD Health International | 215.66B |
| WuXi Biologics | 164.43B |
| Innovent Biologics | 155.25B |
| Sino Biopharmaceutical | 124.24B |
| CSPC Pharmaceutical Group | 112.39B |
| Akeso | 111.46B |